Scienture Holdings, Inc. Common StockSCNX
About: Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Employees: 19
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more funds holding
Funds holding: 9 [Q4 2024] → 9 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.18% less ownership
Funds ownership: 1.07% [Q4 2024] → 0.89% (-0.18%) [Q1 2025]
72% less capital invested
Capital invested by funds: $567K [Q4 2024] → $160K (-$407K) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for SCNX.
Financial journalist opinion
Based on 3 articles about SCNX published over the past 30 days









